Mayo Clinic study shows people with heart devices can 'digest' advanced diagnostic technology safelyOctober 27, 2009Capsule endoscopy risk appears minimal in largest study to date SCOTTSDALE, Ariz. A new Mayo Clinic study suggests that video capsule endoscopy (CE), a procedure that uses wireless technology in diagnosing intestinal disease, is safe for patients with heart devices. Wireless electrical gadgets, such as cell phones, have been shown to interfere with implanted heart devices, including pacemakers and defibrillators. This risk has led medical experts to speculate that capsule endoscopy could similarly cause heart devices to fail. As a result, the noninvasive procedure has been contraindicated by the U.S. Food and Drug Administration (FDA) for patients with cardiac devices. Contraindication means an increased risk may be involved. Generally, the topic has remained in the subject of speculation, although several small studies have found no interference with cardiac devices, and no clinical reports have surfaced linking CE to problems with them. The study concludes that performing a video capsule endoscopy on patients who have cardiac devices appears safe, and, conversely, the cardiac implants don't impair capsule endoscopies. "Ours is the largest study of its kind, with 84 patients (91 capsule studies), and we found no complications from the capsule endoscopy," says Jonathan Leighton, M.D., chair of the Division of Gastroenterology at Mayo Clinic in Arizona and senior author of a report on the research. "The size of the study population should give physicians confidence to use the procedure," says Dr. Leighton. Mayo physicians perform capsule endoscopy routinely, averaging from two to five cases a week at the Arizona site. In the study, Lucinda Harris, M.D., Stephanie Hansel, M.D., reviewed the medical records of 84 patients who underwent CE and had implantable cardiac devices - cardiac pacemakers, defibrillators or left ventricular assist devices - at Mayo Clinic's campuses in Arizona and Rochester, Minn. The patients' average age was 73, and 69 percent had pacemakers. In a large majority of cases (74 percent), the reason for performing the CE was to locate gastrointestinal bleeding. In each case, the capsule explored the entire length of the small bowel. Assessments after the procedure revealed no interference with the implanted cardiac devices. Approved by the FDA in 2000, capsule endoscopy uses a tiny wireless camera to examine the inside of the digestive tract. The patient swallows a vitamin-sized capsule containing a battery-driven camera that travels through the intestines, taking thousands of pictures. It then transmits them to an external receiver from areas deep inside the small bowel previously accessible only through surgery. The device is later excreted through the colon. The use of capsule endoscopy has solved a long-term problem for doctors: visualizing the midsection of the small intestine, which can measure 20 feet in length. Standard endoscopy, done through the mouth or the rectum, can't penetrate deeply enough and requires anesthesia. Now, CE is used to visualize the entire small intestine. Most commonly, it is used to find the source of unexplained bleeding. The procedure is also used to detect the causes of anemia, abdominal pain and certain intestinal diseases. Because cell phones, microwave ovens and other wireless appliances have affected heart devices, physicians were concerned that the radiofrequencies used in CE may potentially interfere with the radiofrequency of heart devices. But in the study, the only research complication occurred when a capsule's receiver stopped working for reasons unrelated to a heart device, according to Dr. Harris, a Mayo gastroenterologist and first author on this study. "There were no problems with the devices interacting," says Dr. Harris. "The data is now out there. We are coming to the point where we know this is a relatively safe procedure. She was scheduled to report on the project Monday, Oct. 26, at a meeting of the American College of Gastroenterology in San Diego. Affirming the procedure's safety when heart devices are present mainly benefits elderly patients, who are the most prone to have implanted devices (primarily pacemakers) and to experience unexplained intestinal bleeding from illnesses or blood-thinning medications. Mayo doctors plan to continue using capsule technology on patients with implants. But even with the positive results of the study, they will continue to do CE as an inpatient procedure. "If it were not contraindicated by the FDA, we would do it as outpatient, and it would reduce costs, just as safely," says Dr. Leighton. Mayo Clinic |
|||||||||||||||||||||
| Related Capsule Endoscopy Current Events and Capsule Endoscopy News Articles Colon capsule endoscopy diagnoses 64% of total polyps detected by conventional colonoscopy Capsule endoscopy for exploring the colon in a minimally invasive manner diagnoses 64% of all lesions located by means of conventional colonoscopy. A breakthrough in diagnosis of enteric lesions Capsule endoscopy (CE), which is virtually a micro-camera, is a revolutionary diagnostic tool in diagnosing small bowel diseases, and CE can obtain 40-60 thousand images of the GI tract, though the number of the images for the lesions is smaller than 500 in most of the patients. Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding A study by researchers in Japan concludes that Double Balloon Endoscopy (DBE) was very useful in the diagnosis of obscure gastrointestinal (GI) bleeding and had a therapeutic impact on the majority of patients. What is the clinical features of primary aortoenteric fistula? PAEF is a rare but often life-threatening cause of massive gastrointestinal bleeding. PAEFs have a mortality rate of nearly 100% in the absence of surgical intervention, and in most case, the diagnosis is not established preoperatively. Bowel prep oral sodium phosphate equal to fasting before capsule endoscopy for obscure GI bleeding According to a new study from researchers in France, bowel preparation with oral sodium phosphate for capsule endoscopy in patients with obscure gastrointestinal (GI) bleeding is no better at cleansing the small bowel than the standard method of preparation, which is an eight-hour fast before the procedure. How does sodium phosphate combined with bisacodyl affect small intestine? Capsule endoscopy is a well accepted tool for evaluation of small bowel pathologies (e.g., bleeding sources). However, it has some limitations due to restricted recording time and reduced visibility by air and residual material. Capsule Endoscopy Diagnoses More Crohn's Disease Recurrence After Surgery Than Colonoscopy Research from La Fe University Hospital in Valencia, Spain shows that capsule endoscopy diagnoses more Crohn's disease recurrence after surgery than colonoscopy. Capsule endoscopy led to changes in therapy for more than half of the patients studied. More Capsule Endoscopy Current Events and Capsule Endoscopy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||